If you’re looking at treatment options for certain kinds of psoriasis or arthritis, you may want to learn more about Enbrel (etanercept). The active ingredient in Enbrel is etanercept. An active ...
THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...
Once weekly ENBREL significantly reduced rheumatoid arthritis pain, inflammation & improved function
THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., June 19, 2003 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that patients receiving ENBREL(R) ...
May 23, 2005 — The European Commission has approved a 50-mg/mL formulation of etanercept injection for the treatment of rheumatoid arthritis, and the U.K.'s Medicine and Healthcare Products Regulatory ...
Rhodes, Greece, 5 October 2006 -- There was good news for psoriasis patients today as the latest study confirming the established safety profile of ENBREL® (etanercept) for up to 2.5 years , was ...
Sofusa is a drug delivery platform technology which delivers biologic therapies through the skin directly into the lymphatic system with potential to improve efficacy and safety and reduce the ...
Sorrento Therapeutics announced that the first patient has been treated in a phase 1b proof-of-concept, open-label study to assess the safety and pilot efficacy of Enbrel administered by the Sofusa ...
For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...
Enbrel significantly improves scalp involvement in patients with moderate to severe plaque psoriasis
Amgen and Pfizer Inc. announced results from a new trial that demonstrated Enbrel (etanercept) significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results